The portal would be made operational in phases. The apex health research body, ICMR, is in the process of developing a vaccine portal which will provide information related to the COVID-19 vaccine development in India and abroad, with majority of the updates in several regional languages in addition to English. The aim of creating the portal … Read more
NEW DELHI: Preliminary results of phase 1 clinical trials of the Bharat Biotech-ICMR developed Covid-19 vaccine, Covaxin, suggest that the vaccine is safe, principal investigators conducting the trials told ET. The vaccine is being tested on 375 volunteers who have enrolled at 12 sites in India. Two doses of the vaccine are being administered to … Read more
New Delhi: Bharat Biotech will wrap up the screening of volunteers for the first phase of human clinical trials for its Covid-19 vaccine Covaxin by the end of July and select 375 of them to begin dosing by early August. The company developed Covaxin in collaboration with the Indian Council of Medical Research-National Institute of … Read more